Investor

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

Selected as best IPO in 2019

FluoGuide won the 2019 share price development award in the micro-cap category and also received the honorary quality award (Affärsvärlden’s IPO Guide).

Calendar & Events

Presentation at ØU Life Science

25 November 2020
Presentation at ØU Life Science, registration is required

Read more here

Q4-2020 report

26 February 2021
Q4-2020 and year-end report 2020 (target release time before 9.00 AM)

Calendar &
upcoming reports


26 February 2021 (morning)

Q4-2020 and year-end report 2020

Show all posts